Company Information

DR. LAL PATHLABS LTD.

NSE : LALPATHLABBSE : 539524ISIN CODE : INE600L01024Industry : Hospital & Healthcare ServicesHouse : Arvind Lal
BSE2383.5553.55 (+2.3 %)
PREV CLOSE ( ) 2330.00
OPEN PRICE ( ) 2325.05
BID PRICE (QTY) 2382.10 (6)
OFFER PRICE (QTY) 2385.05 (27)
VOLUME 5097
TODAY'S LOW / HIGH ( )2325.00 2388.75
52 WK LOW / HIGH ( )1888.85 2766.85
NSE2375.1544.5 (+1.91 %)
PREV CLOSE( ) 2330.65
OPEN PRICE ( ) 2330.65
BID PRICE (QTY) 2373.95 (8)
OFFER PRICE (QTY) 2375.25 (220)
VOLUME 45170
TODAY'S LOW / HIGH( ) 2330.65 2385.00
52 WK LOW / HIGH ( )1888.1 2767.1
ChairmanArvind Lal
Managing DirectorOm Prakash Manchanda
Company SecretaryVinay Gujral
Non Executive DirectorRahul Sharma
Promoter & Non-Executive DirectorArchana Lal Erdmann
Non Executive Independent DirectorSunil Varma
Somya Satsangi
Rohit Bhasin
Arun Duggal
Rajit Mehta
Gurinder Singh Kalra
Whole Time DirectorVandana Lal
Incorporation Year : 14-02 1995

Registered Office :

Address : Block E,Sector 18,Rohini New Delhi,
Delhi-110085 .

Phone : 011-49885050

Email :  cs@lalpathlabs.com 

Industry : Hospital & Healthcare Services

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.